Page 12 - Mitchell Warren News Today

When will the US send coronavirus vaccines to India? it may not have the doses SECTIONS When will the US send coronavirus vaccines to India? it may not have the dosesBy Drew Armstrong and Josh Wingrove, Bloomberg Last Updated: May 16, 2021, 06:56 AM IST Share Synopsis Across the US, there are more than 27 million unused Moderna Inc. doses and 35 million from Pfizer Inc. and BioNTech SE, according to data compiled by the Centers for Disease Control and Prevention. That’s led to calls by promin...

Why isn’t the U.S. sharing its extra vaccine doses with the rest of the world? America led the world in buying up the messenger RNA vaccines that have proven most effective against Covid-19. It’s now starting to lead the world in not using them. Across the U.S., there are more than 27 million unused Moderna Inc. doses and 35 million from Pfizer Inc. and BioNTech SE, according to data compiled by the Centers for Disease Control and Prevention. That’s led to calls by prominent public hea...

Author of the article: Drew Armstrong and Josh Wingrove Publishing date: May 15, 2021  •  2 hours ago  •  6 minute read  •  Article content (Bloomberg) — Why isn’t the U.S. sharing its extra vaccine doses with the rest of the world?  America led the world in buying up the messenger RNA vaccines that have proven most effective against Covid-19. It’s now starting to lead the world in not using them.  We apologize, but this video has fai...

Why isn’t the U.S. sharing its extra vaccine doses with the rest of the world? America led the world in buying up the messenger RNA vaccines that have proven most effective against COVID-19. It’s now starting to lead the world in not using them. Across the U.S., there are more than 27 million unused Moderna Inc. doses and 35 million from Pfizer Inc. and BioNTech SE, according to data compiled by the Centers for Disease Control and Prevention. That’s led to calls by prominent publ...

In a little under a year, scientists developed several vaccines against COVID-19. But as we line up for our shots, we are still living in the shadow of another pandemic. The search for a vaccine against HIV, the virus that causes AIDS, has been ongoing for nearly four decades. To this day, only one large-scale trial has demonstrated even marginal efficacy at preventing infection from the virus: the RV144 trial in Thailand—the largest HIV vaccine trial in history. After HIV was discovered in 1...

Joy Kaiser, Who Saw a Medical Need in South Africa, Dies at 90 With her husband, she founded an organization devoted to increasing the number of Black medical professionals. She died of Covid-19. Joy Kaiser was the wife of an American diplomat in South Africa during apartheid and after her husband retired, the couple could not forget the injustice of apartheid. So they founded a group to help build the medical profession among Blacks there.Credit...via Kaiser family Feb. 22, 2021 This obituary ...

Monday, 8 February 2021, 4:45 pm HIV science has advanced but policies and programmes have been slow to respond towards ending AIDS, said Mitchell Warren, co-chair of the global conference on HIV Research for Prevention (HIVR4P) and Executive Director of AVAC (Global Advocacy for HIV Prevention). Scientific advances have seen huge gains on HIV prevention and treatment fronts. Sadly, what has not changed is the lack of equity in the response. Those who are the most marginalized, most stigmatis...

We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks down the science. Results of a “proof of concept” study presented at the virtual 4th Research for HIV Prevention Conference last week show...

National February 6, 2021 LAHORE: Global funding for COVID-19 vaccine development has exceeded 10 times in less than a year the amount allocated for HIV and TB research and development in 11 years. “A staggering amount of $103.8 billion has been thrust into COVID-19 vaccine development within a period of just 11 months of 2020 as compared to a paltry $9.5 billion ($8.5 billion for HIV and $1billion for TB) for HIV and TB research and vaccine development during 11-year period from 2009 to 201...

Getty Images The start of this year’s HIV Research for Prevention Conference brings with it new findings show the potential of special antibodies to prevent HIV infection This antibody can make people 75% less likely to become infected with a third of existing strains of HIV Bhekisisa unpacks the study and breaks down the key concepts There’s a new player in the HIV prevention field. Newly released results from the 4th HIV Research for Prevention Conference offers fresh insight into how the...